# Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions

> **NCT01665222** · PHASE1 · COMPLETED · sponsor: **Ranbaxy Inc.** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Morphine Sulfate

## Key facts

- **NCT ID:** NCT01665222
- **Lead sponsor:** Ranbaxy Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-10
- **Final completion:** 2006-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01665222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01665222, "Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01665222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*